Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-088225
Filing Date
2022-03-29
Accepted
2022-03-29 16:56:34
Documents
5
Effectiveness Date
2022-03-29

Document Format Files

Seq Description Document Type Size
1 S-8 d324691ds8.htm S-8 31756
2 EX-5.1 d324691dex51.htm EX-5.1 5286
3 EX-23.1 d324691dex231.htm EX-23.1 1419
4 EX-FILING FEES d324691dexfilingfees.htm EX-FILING FEES 19801
5 GRAPHIC g324691g55b97.jpg GRAPHIC 3280
  Complete submission text file 0001193125-22-088225.txt   63955
Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263953 | Film No.: 22781703
SIC: 2836 Biological Products, (No Diagnostic Substances)